Trait
Headache
Cephalgia, or pain sensed in various parts of the head, not confined to the area of distribution of any nerve.
Summary
- Also called
- Headaches
- Body system
- Abnormality of the nervous system
Reference genomeGRCh38hg38
Positions on gene and variant pages follow this choice, in this browser.
Read the genes linked to Headache, and the rest of your genome, with one test.
From $449Free shipping · Results in 6–8 weeks
Get my Genome Test265 genes linked to Headache
Changes in these genes cause rare conditions in which Headache is seen. Most people with this trait have none of those conditions, and a gene on this list says nothing about anyone's own genome.
| Gene | How often it is seen | Conditions |
|---|---|---|
| BCAT2branched chain amino acid transaminase 2 | Always | In 1 condition |
| CST3cystatin C | Always | In 1 condition |
| FARSBphenylalanyl-tRNA synthetase subunit beta | Always | In 1 condition |
| KLklotho | Always | In 1 condition |
| LIG3DNA ligase 3 | Always | In 1 condition |
| LRRC7leucine rich repeat containing 7 | Always | In 1 condition |
| LYNLYN proto-oncogene, Src family tyrosine kinase | Always | In 1 condition |
| MCATmalonyl-CoA-acyl carrier protein transacylase | Always | In 1 condition |
| MECRmitochondrial trans-2-enoyl-CoA reductase | Always | In 2 conditions |
| NLRP3NLR family pyrin domain containing 3 | Always | In 4 conditions |
| PIGTphosphatidylinositol glycan anchor biosynthesis class T | Always | In 1 condition |
| POLG2DNA polymerase gamma 2, accessory subunit | Always | In 1 condition |
| RRP12ribosomal RNA processing 12 homolog | Always | In 2 conditions |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Always | In 2 conditions |
| SLC25A4solute carrier family 25 member 4 | Always | In 1 condition |
| SOSTsclerostin | Always | In 3 conditions |
| TNFRSF11ATNF receptor superfamily member 11a | Always | In 1 condition |
| TOP2BDNA topoisomerase II beta | Always | In 1 condition |
| VHLvon Hippel-Lindau tumor suppressor | Always | In 2 conditions |
| ADA2adenosine deaminase 2 | Very often (80–99%) | In 3 conditions |
| APPamyloid beta precursor protein | Very often (80–99%) | In 1 condition |
| CCM2CCM2 scaffold protein | Very often (80–99%) | In 3 conditions |
| DKK1dickkopf Wnt signaling pathway inhibitor 1 | Very often (80–99%) | In 1 condition |
| ELANEelastase, neutrophil expressed | Very often (80–99%) | In 1 condition |
| EPORerythropoietin receptor | Very often (80–99%) | In 2 conditions |
| FASFas cell surface death receptor | Very often (80–99%) | In 3 conditions |
| HLA-Bmajor histocompatibility complex, class I, B | Very often (80–99%) | In 3 conditions |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Very often (80–99%) | In 2 conditions |
| JAK2Janus kinase 2 | Very often (80–99%) | In 4 conditions |
| KRIT1KRIT1 ankyrin repeat containing | Very often (80–99%) | In 2 conditions |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Very often (80–99%) | In 1 condition |
| PDCD10programmed cell death 10 | Very often (80–99%) | In 3 conditions |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Very often (80–99%) | In 2 conditions |
| PTENphosphatase and tensin homolog | Very often (80–99%) | In 1 condition |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Very often (80–99%) | In 3 conditions |
| SLC19A2solute carrier family 19 member 2 | Very often (80–99%) | In 1 condition |
| AIPAHR interacting HSP90 co-chaperone | Often (30–79%) | In 2 conditions |
| AKT1AKT serine/threonine kinase 1 | Often (30–79%) | In 1 condition |
| ASXL1ASXL transcriptional regulator 1 | Often (30–79%) | In 1 condition |
| BAP1BRCA1 associated deubiquitinase 1 | Often (30–79%) | In 1 condition |
Show 225 more genes
| Gene | How often it is seen | Conditions |
|---|---|---|
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Often (30–79%) | In 3 conditions |
| C1Rcomplement C1r | Often (30–79%) | In 1 condition |
| C1Scomplement C1s | Often (30–79%) | In 1 condition |
| C4Acomplement C4A (Chido/Rodgers blood group) | Often (30–79%) | In 1 condition |
| CALRcalreticulin | Often (30–79%) | In 1 condition |
| CCR1C-C motif chemokine receptor 1 | Often (30–79%) | In 1 condition |
| CD46CD46 molecule | Often (30–79%) | In 1 condition |
| CDH23cadherin related 23 | Often (30–79%) | In 3 conditions |
| CFHcomplement factor H | Often (30–79%) | In 1 condition |
| CFIcomplement factor I | Often (30–79%) | In 1 condition |
| CLCN2chloride voltage-gated channel 2 | Often (30–79%) | In 2 conditions |
| CMPK2cytidine/uridine monophosphate kinase 2 | Often (30–79%) | In 1 condition |
| CPT2carnitine palmitoyltransferase 2 | Often (30–79%) | In 1 condition |
| CTNNB1catenin beta 1 | Often (30–79%) | In 1 condition |
| EPM2AEPM2A glucan phosphatase, laforin | Often (30–79%) | In 1 condition |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Often (30–79%) | In 1 condition |
| GCDHglutaryl-CoA dehydrogenase | Often (30–79%) | In 1 condition |
| GDF3growth differentiation factor 3 | Often (30–79%) | In 1 condition |
| GDF6growth differentiation factor 6 | Often (30–79%) | In 1 condition |
| GNAQG protein subunit alpha q | Often (30–79%) | In 1 condition |
| GPR101G protein-coupled receptor 101 | Often (30–79%) | In 2 conditions |
| HELLPARHELLP associated long non-coding RNA | Often (30–79%) | In 1 condition |
| IFNGR1interferon gamma receptor 1 | Often (30–79%) | In 1 condition |
| IL10interleukin 10 | Often (30–79%) | In 1 condition |
| IL12Ainterleukin 12A | Often (30–79%) | In 1 condition |
| IL12A-AS1IL12A antisense RNA 1 | Often (30–79%) | In 1 condition |
| IL12Binterleukin 12B | Often (30–79%) | In 1 condition |
| IL23Rinterleukin 23 receptor | Often (30–79%) | In 1 condition |
| IRF3interferon regulatory factor 3 | Often (30–79%) | In 1 condition |
| JAM2junctional adhesion molecule 2 | Often (30–79%) | In 1 condition |
| KCNA1potassium voltage-gated channel subfamily A member 1 | Often (30–79%) | In 2 conditions |
| KITKIT proto-oncogene, receptor tyrosine kinase | Often (30–79%) | In 2 conditions |
| KLRC4killer cell lectin like receptor C4 | Often (30–79%) | In 1 condition |
| KYNUkynureninase | Often (30–79%) | In 1 condition |
| LPIN2lipin 2 | Often (30–79%) | In 1 condition |
| LRP6LDL receptor related protein 6 | Often (30–79%) | In 1 condition |
| MEFVMEFV innate immunity regulator, pyrin | Often (30–79%) | In 2 conditions |
| MEN1menin 1 | Often (30–79%) | In 2 conditions |
| MEOX1mesenchyme homeobox 1 | Often (30–79%) | In 1 condition |
| MLXMAX dimerization protein MLX | Often (30–79%) | In 1 condition |
| MPLMPL proto-oncogene, thrombopoietin receptor | Often (30–79%) | In 2 conditions |
| MRPS2mitochondrial ribosomal protein S2 | Often (30–79%) | In 1 condition |
| MT-ATP6mitochondrially encoded ATP synthase membrane subunit 6 | Often (30–79%) | In 1 condition |
| MVKmevalonate kinase | Often (30–79%) | In 1 condition |
| MYORGmyogenesis regulating glycosidase | Often (30–79%) | In 1 condition |
| NAA60N-alpha-acetyltransferase 60, NatF catalytic subunit | Often (30–79%) | In 1 condition |
| NF1neurofibromin 1 | Often (30–79%) | In 2 conditions |
| NF2NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor | Often (30–79%) | In 2 conditions |
| NFE2L2NFE2 like bZIP transcription factor 2 | Often (30–79%) | In 1 condition |
| NHLRC1NHL repeat containing E3 ubiquitin protein ligase 1 | Often (30–79%) | In 1 condition |
| NLRP12NLR family pyrin domain containing 12 | Often (30–79%) | In 1 condition |
| NOTCH3notch receptor 3 | Often (30–79%) | In 1 condition |
| PDGFBplatelet derived growth factor subunit B | Often (30–79%) | In 2 conditions |
| PDGFRBplatelet derived growth factor receptor beta | Often (30–79%) | In 1 condition |
| PFN1profilin 1 | Often (30–79%) | In 1 condition |
| PIGAphosphatidylinositol glycan anchor biosynthesis class A | Often (30–79%) | In 1 condition |
| POLGDNA polymerase gamma, catalytic subunit | Often (30–79%) | In 1 condition |
| RYR1ryanodine receptor 1 | Often (30–79%) | In 1 condition |
| SH2B3SH2B adaptor protein 3 | Often (30–79%) | In 2 conditions |
| SLC20A2solute carrier family 20 member 2 | Often (30–79%) | In 1 condition |
| SLC2A1solute carrier family 2 member 1 | Often (30–79%) | In 4 conditions |
| SLC39A14solute carrier family 39 member 14 | Often (30–79%) | In 1 condition |
| SMAD3SMAD family member 3 | Often (30–79%) | In 1 condition |
| SMARCAL1SNF2 related chromatin remodeling annealing helicase 1 | Often (30–79%) | In 1 condition |
| SMARCB1SWI/SNF related BAF chromatin remodeling complex subunit B1 | Often (30–79%) | In 1 condition |
| SMARCE1SWI/SNF related BAF chromatin remodeling complex subunit E1 | Often (30–79%) | In 1 condition |
| SMOsmoothened, frizzled class receptor | Often (30–79%) | In 1 condition |
| SRSF2serine and arginine rich splicing factor 2 | Often (30–79%) | In 1 condition |
| STAT4signal transducer and activator of transcription 4 | Often (30–79%) | In 2 conditions |
| SUFUSUFU negative regulator of hedgehog signaling | Often (30–79%) | In 1 condition |
| TBK1TANK binding kinase 1 | Often (30–79%) | In 1 condition |
| TERTtelomerase reverse transcriptase | Often (30–79%) | In 1 condition |
| TET2tet methylcytosine dioxygenase 2 | Often (30–79%) | In 2 conditions |
| THPOthrombopoietin | Often (30–79%) | In 1 condition |
| TICAM1TIR domain containing adaptor molecule 1 | Often (30–79%) | In 1 condition |
| TLR3toll like receptor 3 | Often (30–79%) | In 1 condition |
| TLR4toll like receptor 4 | Often (30–79%) | In 1 condition |
| TLR7toll like receptor 7 | Often (30–79%) | In 1 condition |
| TNFRSF1ATNF receptor superfamily member 1A | Often (30–79%) | In 1 condition |
| TP53tumor protein p53 | Often (30–79%) | In 3 conditions |
| TRAF3TNF receptor associated factor 3 | Often (30–79%) | In 1 condition |
| TRAF7TNF receptor associated factor 7 | Often (30–79%) | In 1 condition |
| TRANK1tetratricopeptide repeat and ankyrin repeat containing 1 | Often (30–79%) | In 1 condition |
| UBAC2UBA domain containing 2 | Often (30–79%) | In 1 condition |
| UNC93B1unc-93B1 regulator of TLR signaling | Often (30–79%) | In 1 condition |
| VSX1visual system homeobox 1 | Often (30–79%) | In 1 condition |
| XPR1xenotropic and polytropic retrovirus receptor 1 | Often (30–79%) | In 1 condition |
| ACP5acid phosphatase 5, tartrate resistant | Sometimes (5–29%) | In 1 condition |
| ACTA1actin alpha 1, skeletal muscle | Sometimes (5–29%) | In 1 condition |
| ACTN4actinin alpha 4 | Sometimes (5–29%) | In 1 condition |
| ADARadenosine deaminase RNA specific | Sometimes (5–29%) | In 1 condition |
| ADRA2Badrenoceptor alpha 2B | Sometimes (5–29%) | In 1 condition |
| ALKALK receptor tyrosine kinase | Sometimes (5–29%) | In 1 condition |
| ALX4ALX homeobox 4 | Sometimes (5–29%) | In 1 condition |
| AMER1APC membrane recruitment protein 1 | Sometimes (5–29%) | In 1 condition |
| ANKFY1ankyrin repeat and FYVE domain containing 1 | Sometimes (5–29%) | In 1 condition |
| ANLNanillin, actin binding protein | Sometimes (5–29%) | In 1 condition |
| AP2S1adaptor related protein complex 2 subunit sigma 1 | Sometimes (5–29%) | In 1 condition |
| APOL1apolipoprotein L1 | Sometimes (5–29%) | In 1 condition |
| ARHGAP24Rho GTPase activating protein 24 | Sometimes (5–29%) | In 1 condition |
| ARHGDIARho GDP dissociation inhibitor alpha | Sometimes (5–29%) | In 1 condition |
| ATP1A2ATPase Na+/K+ transporting subunit alpha 2 | Sometimes (5–29%) | In 1 condition |
| ATP1A3ATPase Na+/K+ transporting subunit alpha 3 | Sometimes (5–29%) | In 1 condition |
| ATRXATRX chromatin remodeler | Sometimes (5–29%) | In 1 condition |
| AVILadvillin | Sometimes (5–29%) | In 1 condition |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Sometimes (5–29%) | In 1 condition |
| CACNA1Dcalcium voltage-gated channel subunit alpha1 D | Sometimes (5–29%) | In 1 condition |
| CBLIFcobalamin binding intrinsic factor | Sometimes (5–29%) | In 1 condition |
| CCND1cyclin D1 | Sometimes (5–29%) | In 1 condition |
| CD2APCD2 associated protein | Sometimes (5–29%) | In 1 condition |
| CDC73cell division cycle 73 | Sometimes (5–29%) | In 2 conditions |
| CDKN1Bcyclin dependent kinase inhibitor 1B | Sometimes (5–29%) | In 1 condition |
| CDKN2Bcyclin dependent kinase inhibitor 2B | Sometimes (5–29%) | In 1 condition |
| CNNM2cyclin and CBS domain divalent metal cation transport mediator 2 | Sometimes (5–29%) | In 1 condition |
| CNTN2contactin 2 | Sometimes (5–29%) | In 1 condition |
| COL4A3collagen type IV alpha 3 chain | Sometimes (5–29%) | In 1 condition |
| COQ8Bcoenzyme Q8B | Sometimes (5–29%) | In 1 condition |
| CORINcorin, serine peptidase | Sometimes (5–29%) | In 1 condition |
| CRB2crumbs cell polarity complex component 2 | Sometimes (5–29%) | In 1 condition |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Sometimes (5–29%) | In 1 condition |
| CTNND2catenin delta 2 | Sometimes (5–29%) | In 1 condition |
| CYP11B1cytochrome P450 family 11 subfamily B member 1 | Sometimes (5–29%) | In 1 condition |
| CYP11B2cytochrome P450 family 11 subfamily B member 2 | Sometimes (5–29%) | In 1 condition |
| DAAM2dishevelled associated activator of morphogenesis 2 | Sometimes (5–29%) | In 1 condition |
| EMP2epithelial membrane protein 2 | Sometimes (5–29%) | In 1 condition |
| F8coagulation factor VIII | Sometimes (5–29%) | In 2 conditions |
| FGFR2fibroblast growth factor receptor 2 | Sometimes (5–29%) | In 2 conditions |
| FGFR3fibroblast growth factor receptor 3 | Sometimes (5–29%) | In 1 condition |
| FLI1Fli-1 proto-oncogene, ETS transcription factor | Sometimes (5–29%) | In 1 condition |
| FLT1fms related receptor tyrosine kinase 1 | Sometimes (5–29%) | In 1 condition |
| GAPVD1GTPase activating protein and VPS9 domains 1 | Sometimes (5–29%) | In 1 condition |
| GBA1glucosylceramidase beta 1 | Sometimes (5–29%) | In 1 condition |
| GNB2G protein subunit beta 2 | Sometimes (5–29%) | In 1 condition |
| HACD13-hydroxyacyl-CoA dehydratase 1 | Sometimes (5–29%) | In 1 condition |
| HLA-DPA1major histocompatibility complex, class II, DP alpha 1 | Sometimes (5–29%) | In 1 condition |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Sometimes (5–29%) | In 1 condition |
| HTRA1HtrA serine peptidase 1 | Sometimes (5–29%) | In 1 condition |
| IFIH1interferon induced with helicase C domain 1 | Sometimes (5–29%) | In 1 condition |
| INF2inverted formin 2 | Sometimes (5–29%) | In 1 condition |
| IRAK1interleukin 1 receptor associated kinase 1 | Sometimes (5–29%) | In 1 condition |
| ITGA7integrin subunit alpha 7 | Sometimes (5–29%) | In 1 condition |
| KANK2KN motif and ankyrin repeat domains 2 | Sometimes (5–29%) | In 1 condition |
| KCNJ5potassium inwardly rectifying channel subfamily J member 5 | Sometimes (5–29%) | In 1 condition |
| KCNQ2potassium voltage-gated channel subfamily Q member 2 | Sometimes (5–29%) | In 1 condition |
| KIF23kinesin family member 23 | Sometimes (5–29%) | In 1 condition |
| LAMA5laminin subunit alpha 5 | Sometimes (5–29%) | In 1 condition |
| LRP5LDL receptor related protein 5 | Sometimes (5–29%) | In 2 conditions |
| LSM11LSM11, U7 small nuclear RNA associated | Sometimes (5–29%) | In 1 condition |
| MAGI2membrane associated guanylate kinase, WW and PDZ domain containing 2 | Sometimes (5–29%) | In 1 condition |
| MAP3K20mitogen-activated protein kinase kinase kinase 20 | Sometimes (5–29%) | In 1 condition |
| MARCHF6membrane associated ring-CH-type finger 6 | Sometimes (5–29%) | In 1 condition |
| MSX2msh homeobox 2 | Sometimes (5–29%) | In 3 conditions |
| MT-TL2mitochondrially encoded tRNA-Leu (CUN) 2 | Sometimes (5–29%) | In 1 condition |
| MTHFRmethylenetetrahydrofolate reductase | Sometimes (5–29%) | In 1 condition |
| MYL2myosin light chain 2 | Sometimes (5–29%) | In 1 condition |
| MYO1Emyosin IE | Sometimes (5–29%) | In 1 condition |
| NAGSN-acetylglutamate synthase | Sometimes (5–29%) | In 1 condition |
| NOTCH2notch receptor 2 | Sometimes (5–29%) | In 1 condition |
| NPHS1NPHS1 adhesion molecule, nephrin | Sometimes (5–29%) | In 1 condition |
| NPHS2NPHS2 stomatin family member, podocin | Sometimes (5–29%) | In 1 condition |
| NPPAnatriuretic peptide A | Sometimes (5–29%) | In 1 condition |
| NR3C1nuclear receptor subfamily 3 group C member 1 | Sometimes (5–29%) | In 1 condition |
| NRASNRAS proto-oncogene, GTPase | Sometimes (5–29%) | In 1 condition |
| NUP107nucleoporin 107 | Sometimes (5–29%) | In 1 condition |
| NUP133nucleoporin 133 | Sometimes (5–29%) | In 1 condition |
| NUP160nucleoporin 160 | Sometimes (5–29%) | In 1 condition |
| NUP205nucleoporin 205 | Sometimes (5–29%) | In 1 condition |
| NUP37nucleoporin 37 | Sometimes (5–29%) | In 1 condition |
| NUP85nucleoporin 85 | Sometimes (5–29%) | In 1 condition |
| NUP93nucleoporin 93 | Sometimes (5–29%) | In 1 condition |
| PAX2paired box 2 | Sometimes (5–29%) | In 1 condition |
| PLCE1phospholipase C epsilon 1 | Sometimes (5–29%) | In 1 condition |
| PRORPprotein only RNase P catalytic subunit | Sometimes (5–29%) | In 1 condition |
| PRTN3proteinase 3 | Sometimes (5–29%) | In 1 condition |
| PTPROprotein tyrosine phosphatase receptor type O | Sometimes (5–29%) | In 1 condition |
| RACGAP1Rac GTPase activating protein 1 | Sometimes (5–29%) | In 1 condition |
| RAF1Raf-1 proto-oncogene, serine/threonine kinase | Sometimes (5–29%) | In 1 condition |
| RAPGEF2Rap guanine nucleotide exchange factor 2 | Sometimes (5–29%) | In 1 condition |
| RASA1RAS p21 protein activator 1 | Sometimes (5–29%) | In 1 condition |
| RETret proto-oncogene | Sometimes (5–29%) | In 1 condition |
| RHOBTB2Rho related BTB domain containing 2 | Sometimes (5–29%) | In 1 condition |
| RNASEH2Aribonuclease H2 subunit A | Sometimes (5–29%) | In 1 condition |
| RNASEH2Bribonuclease H2 subunit B | Sometimes (5–29%) | In 1 condition |
| RNASEH2Cribonuclease H2 subunit C | Sometimes (5–29%) | In 1 condition |
| RNF168ring finger protein 168 | Sometimes (5–29%) | In 1 condition |
| RNU7-1RNA, U7 small nuclear 1 | Sometimes (5–29%) | In 1 condition |
| SAMD12sterile alpha motif domain containing 12 | Sometimes (5–29%) | In 1 condition |
| SAMHD1SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 | Sometimes (5–29%) | In 1 condition |
| SAT1spermidine/spermine N1-acetyltransferase 1 | Sometimes (5–29%) | In 1 condition |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Sometimes (5–29%) | In 2 conditions |
| SCN5Asodium voltage-gated channel alpha subunit 5 | Sometimes (5–29%) | In 1 condition |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Sometimes (5–29%) | In 1 condition |
| SDHCsuccinate dehydrogenase complex subunit C | Sometimes (5–29%) | In 1 condition |
| SELENONselenoprotein N | Sometimes (5–29%) | In 1 condition |
| SLC1A3solute carrier family 1 member 3 | Sometimes (5–29%) | In 2 conditions |
| SOX5SRY-box transcription factor 5 | Sometimes (5–29%) | In 1 condition |
| SPP1secreted phosphoprotein 1 | Sometimes (5–29%) | In 1 condition |
| STOX1storkhead box 1 | Sometimes (5–29%) | In 1 condition |
| TBC1D8BTBC1 domain family member 8B | Sometimes (5–29%) | In 1 condition |
| TNRC6Atrinucleotide repeat containing adaptor 6A | Sometimes (5–29%) | In 1 condition |
| TPM2tropomyosin 2 | Sometimes (5–29%) | In 1 condition |
| TPM3tropomyosin 3 | Sometimes (5–29%) | In 1 condition |
| TREX1three prime repair exonuclease 1 | Sometimes (5–29%) | In 1 condition |
| TRPC6transient receptor potential cation channel subfamily C member 6 | Sometimes (5–29%) | In 1 condition |
| TWIST1twist family bHLH transcription factor 1 | Sometimes (5–29%) | In 1 condition |
| USP48ubiquitin specific peptidase 48 | Sometimes (5–29%) | In 1 condition |
| USP8ubiquitin specific peptidase 8 | Sometimes (5–29%) | In 1 condition |
| WT1WT1 transcription factor | Sometimes (5–29%) | In 1 condition |
| YEATS2YEATS domain containing 2 | Sometimes (5–29%) | In 1 condition |
| ZEB2zinc finger E-box binding homeobox 2 | Sometimes (5–29%) | In 1 condition |
| CASP10caspase 10 | Rarely (1–4%) | In 1 condition |
| CLCNKBchloride voltage-gated channel Kb | Rarely (1–4%) | In 1 condition |
| COL1A1collagen type I alpha 1 chain | Rarely (1–4%) | In 1 condition |
| COL5A1collagen type V alpha 1 chain | Rarely (1–4%) | In 1 condition |
| COL5A2collagen type V alpha 2 chain | Rarely (1–4%) | In 1 condition |
| FASLGFas ligand | Rarely (1–4%) | In 1 condition |
| SLC12A3solute carrier family 12 member 3 | Rarely (1–4%) | In 1 condition |
| ANO1anoctamin 1 | Not recorded | In 1 condition |
| CYB5R3cytochrome b5 reductase 3 | Not recorded | In 1 condition |
| DNAI1dynein axonemal intermediate chain 1 | Not recorded | In 1 condition |
| MAOAmonoamine oxidase A | Not recorded | In 1 condition |
| TGFB1transforming growth factor beta 1 | Not recorded | In 1 condition |
| TTRtransthyretin | Not recorded | In 1 condition |
| VANGL1VANGL planar cell polarity protein 1 | Not recorded | In 1 condition |
| ZFHX2zinc finger homeobox 2 | Not recorded | In 1 condition |
How often is among people with one of the gene's conditions, the most often across them, as the Human Phenotype Ontology records it. These pages describe traits and the research behind them; they are not a diagnosis, and a doctor or genetic counsellor is the person to ask about symptoms.
Narrower traits
Broader traits
Where this comes from
- The Human Phenotype Ontology, release 2026-09-01: the trait, its names, its definition and the genes linked to it. Find out more at hpo.jax.org.
- Data release 2026.10.16-c6eea6bf.
One test. A lifetime of answers.
From $449Free shipping · Results in 6–8 weeks